Avant cross-licenses with Megan Health

Megan Health (St. Louis, Mo.) granted AVAN exclusive rights to a patent portfolio, which AVAN said supports its Ty800 single-dose oral vaccine against typhoid fever. Ty800 has completed Phase I/II stu...